Short-Term Effectiveness of Medication and Psychosocial Intervention in a Cohort of Newly Diagnosed Patients With Inattention,Impulsivity,and Hyperactivity Problems
Restricted accessOtherFirst published online September, 2010
Short-Term Effectiveness of Medication and Psychosocial Intervention in a Cohort of Newly Diagnosed Patients With Inattention,Impulsivity,and Hyperactivity Problems
Objective: The article discusses the ADHD Observational Research in Europe (ADORE) study that examined the impact of early treatment choices on outcome within the first few months, in previously untreated children with impairing inattention, impulsivity, and hyperactivity. Methods: Data are collected from a longitudinal, observational study conducted in 10 European countries that involve 1,478 children (aged 6 to 18 years) with symptoms of hyperactivity, impulsivity, or inattentiveness. Linear model with a propensity score adjustment compares the decrease in ADHD-RS scores between baseline and last recorded visit across treatment groups (2 to 5 months). Results: At baseline, 49.9% of participants are prescribed pharmacotherapy and 44.3% a psychosocial intervention. Analysis of the effect of treatment on the evolution of ADHD-RS scores shows a positive effect of medications and either an insignificant or negative effect of psychosocial intervention. Conclusions: Early use of medication effectively reduces ADHD symptoms in routine clinical practice in Europe. The effect of psychosocial intervention has to be interpreted cautiously because the number, length, and level of standard of the sessions are not taken into account in the analyses.
Abikoff, H., McGough, J., Vitiello, B., McCracken, J., Davies, M., Walkup, J., et al. (2005). Sequential pharmacotherapy for children with comorbid attention-deficit/hyperactivity and anxiety disorders. Journal of the American Academy of Child and Adolescent Psychiatry , 44, 418-427.
2.
American Academy of Pediatrics. (2001). Clinical practice guideline: Treatment of the school-aged child with attention-deficit/ hyperactivity disorder. Pediatrics, 108, 1033-1044.
3.
American Psychiatric Association. (1994). DSM-IV. Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.
4.
Banaschewski, T., Coghill, D., Santosh, P., Zuddas, A., Asherson, P., Buitelaar, J., et al. (2006). Long-acting medications for the hyperkinetic disorders. A systematic review and European treatment guideline. European Child & Adolescent Psychiatry, 15, 476-495.
5.
DuPaul, G., Power, T., Anastopoulos, A., & Reid, R. ( 1998). ADHD Rating Scale-IV: Checklists, norms, and clinical interpretation. New York: Guilford .
6.
Faraone, S.V., Sergeant, J., Gillberg, C., & Biederman, J. ( 2003). The worldwide prevalence of ADHD: Is it an American condition?World Psychiatry, 2, 104-113.
7.
Goodman, R. ( 1997). The Strengths and Difficulties Questionnaire: A research note. Journal of Child Psychology and Psychiatry, and Allied Disciplines, 38, 581-586.
8.
Guy, W. ( 1976). Clinical Global Impression. ECDEU. Assessment manual for psychopharmacology-revised. Rockville, MD: National Institute of Mental Health.
9.
Hosmer, D., & Lemeshow, S. ( 2001). Applied logistic regression (2nd ed.). New York: John Wiley.
10.
Jadad, A., Boyle, M., Cunningham, C., Kim, M., & Schachar, R. ( 2000). Treatment of attention-deficit/hyperactivity disorder . Evidence Report: Technology Assessment (Summary), 11, i-viii.
11.
King, S., Griffin, S., Hodges, Z., Weatherly, H., Asseburg, C., Richardson, G., et al. (2006). A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technology Assessment , 10, iii-iv, xiii-146.
12.
Klassen, A., Miller, A., Raina, P., Lee, S.K., & Olsen, L. ( 1999). Attention-deficit hyperactivity disorder in children and youth: A quantitative systematic review of the efficacy of different management strategies. Canadian Journal of Psychiatry, 44, 1007-1016.
13.
McClellan, J.M., & Werry, J.S. ( 2003). Evidence-based treatments in child and adolescent psychiatry: An inventory. Journal of the American Academy of Child and Adolescent Psychiatry, 42, 1388-1400.
14.
MTA Cooperative Group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA Cooperative Group. Multimodal treatment study of children with ADHD. Archives of General Psychiatry, 56, 1073-1086.
15.
Preuss, U., Ralston, S.J., Baldursson, G., Falissard, B., Lorenzo, M.J., Rodrigues Pereira, R., et al. (2006). Study design, baseline patient characteristics and intervention in a cross-cultural framework: Results from the ADORE study . European Child & Adolescent Psychiatry, 15(Suppl. 1), i4-i14.
16.
R Development Core Team. (2004). R: A language and environment for statistical computing. Available from http://www.R-project.org
17.
Rappley, M.D. ( 2005). Clinical practice. Attention deficithyperactivity disorder . New England Journal of Medicine, 352, 165-173.
18.
Riley, A.W., Forrest, C.B., Starfield, B., Rebok, G.W., Robertson, J.A., & Green, B.F. ( 2004). The parent report form of the CHIP-child edition: Reliability and validity. Medical Care, 42, 210-220.
19.
Rosenbaum, P., & Rubin, D. ( 1983). The central role of the propensity score in observational studies for causal effect. Biometrika, 70, 41-55.
20.
Santosh, P., & Taylor, E. ( 2000). Stimulant drugs. European Child and Adolescent Psychiatry, 9 (Suppl. 1), 127-143.
21.
Santosh, P., Taylor, E., Swansonc, J., Wigalc, T., Chuangd, S., Daviese, M., et al. (2005). Refining the diagnoses of inattention and overactivity syndromes: A reanalysis of the Multimodal Treatment study of attention deficit hyperactivity disorder (ADHD) based on ICD-10 criteria for hyperkinetic disorder. Clinical Neuroscience Research, 5, 307-314.
22.
Scottish Intercollegiate Guidelines Network. ( 2001). Attention deficit and hyperkinetic disorders in children and young people: A national clinical guideline (SIGN Publication No. 52) . Edinburgh: Author.
23.
Shaffer, D., Gould, M.S., Brasic, J., Ambrosini, P., Fisher, P., Bird, H., et al. (1983). A children’s global assessment scale (CGAS). Archives of General Psychiatry, 40, 1228-1231.
24.
Statistical Analysis Software . (2004). 9.1ed. Cary, NC: SAS Institute.
